Description

NSE circular announcing changes to Enhanced Surveillance Measure (ESM) framework effective March 25, 2026, including one security moving from Stage I to Stage II and consolidated list of 40+ securities under ESM.

Summary

NSE has announced changes to the Enhanced Surveillance Measure (ESM) framework effective March 25, 2026. One security (VILINBIO - Vilin Bio Med Limited) is moving from ESM Stage I to Stage II, while no new securities are being added to Stage I and no securities are being excluded from the ESM framework. The consolidated ESM list contains 40+ securities across Stage I and Stage II.

Key Points

  • No new securities shortlisted for ESM Stage I w.e.f. March 25, 2026
  • VILINBIO (Vilin Bio Med Limited, ISIN: INE0L4V01013) moves from ESM Stage I to Stage II w.e.f. March 25, 2026
  • No securities moving from ESM Stage II back to Stage I
  • No securities excluded from the ESM framework
  • Consolidated ESM list includes 19 securities in Stage II and 21+ securities in Stage I

Regulatory Changes

The ESM framework periodically reviews securities based on surveillance criteria. Stage II of ESM imposes stricter trading restrictions compared to Stage I, including trade-to-trade settlement and potential price band restrictions. VILINBIO’s escalation to Stage II reflects continued surveillance concerns.

Compliance Requirements

  • Trading members must ensure compliance with ESM Stage I and Stage II trading restrictions for all listed securities
  • Clients holding or intending to trade in ESM-listed securities must be informed of applicable restrictions
  • Settlement for ESM Stage II securities is on a trade-to-trade basis

Important Dates

  • Effective Date: March 25, 2026 — All ESM changes come into effect

Impact Assessment

Stage II Securities (19 total): ABMINTLLTD, ASCOM, CURAA, GSTL, HOACFOODS, KODYTECH, KSR, MOXSH, NORBTEAEXP, PARASPETRO, S&SPOWER, SANGINITA, SOMATEX, TAKE, TGL, UCL, UNIVPHOTO, VILINBIO (newly added), VIPULLTD

Stage I Securities (partial list): AAKASH, AFIL, AKIKO, AMCL, AMIABLE, ARVEE, ASLIND, AUSOMENT, AXITA, BESTAGRO, BIKEWO, BLBLIMITED, BLUEPEBBLE, BOHRAIND, BONLON, BORANA, CAPTRUST, CBAZAAR, CKKRETAIL, CPS, DCMFINSERV (and more)

Securities under ESM face reduced liquidity, mandatory trade-to-trade settlement (Stage II), and heightened investor scrutiny. Retail investors are particularly impacted as intraday trading is not permitted for Stage II securities. VILINBIO’s upgrade to Stage II signals increased regulatory concern about its trading patterns.

Impact Justification

ESM changes impose significant trading restrictions on affected securities; Stage II carries stricter trading curbs. Movement of VILINBIO to Stage II and a large consolidated list of 40+ securities directly impacts traders and investors in these stocks.